Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic carbon dioxide therapy for periodic breathing in heart failure
2010-019464-37Phase 2Completed
- Sponsor
- Fondazione Toscana Gabriele Monasterio
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Carbon dioxide in central sleep apnea (CSA) and heart failure (HF), sponsored by Fondazione Toscana Gabriele Monasterio. Primary endpoint: Apnea–hypopnea index. Started Mar 2012; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
central sleep apnea (CSA)heart failure (HF)
Beyond the preview
Go deeper on 2010-019464-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019464-37.